| Date | Title | Description |
| 13.05.2025 | Fangzhou CEO Honored at 2025 VBEF Conference as Company Showcases AI Medical Innovations | SUZHOU, China, May 13, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, participated in the prestigious 2025 VBEF Future Healthcare and Medicine Conf... |
| 06.05.2025 | Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform | GUANGZHOU, China, May 6, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the availability of Otsuka Pharmaceutical's third-generation tyro... |
| 17.04.2025 | Fangzhou Launches Partnership for "AI + Hepatitis Prevention & Control Training Center" at the Greater Bay Area International Liver Disease Forum | GUANGZHOU, China, April 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions, partnered with the Guangdong Provincial Liver Disease Institute at the ... |
| 14.04.2025 | Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation Salon | GUANGZHOU, China, April 14, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, participated in the "AI Empowers Biopharma" exchange pan... |
| 10.04.2025 | Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models | GUANGZHOU, China, April 10, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, emerged as the sole digital health innovator invited to the Modern... |
| 03.04.2025 | Fangzhou Designated as a 2024 National High-Tech Enterprise Amid Record Growth | BEIJING, April 3, 2025 /PRNewswire/ -- Beijing Fangyixing Information Technology Co., Ltd. ("Fangyixing"), a subsidiary of China's leading Internet healthcare solutions provider Fangzhou Inc. ("Fangzhou" or the "Com... |
| 28.03.2025 | Fangzhou Inc. Named Among Guangzhou's Top AI Innovators for Intelligent Healthcare Platform | GUANGZHOU, China, March 28, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, has been named to the 2024 Guangzhou Artificial Intelligence Innovation ... |
| 27.03.2025 | Fangzhou Inc.: A New Era in AI-Driven Healthcare | Fangzhou Inc. is not just a name in the healthcare sector; it’s a beacon of innovation. The company has emerged as a leader in Internet healthcare solutions, harnessing the power of artificial intelligence (AI) to reshape chronic disease ma... |
| 26.03.2025 | Fangzhou Inc. Partners with Tencent Health and Tencent Cloud to Accelerate Development of AI-Enabled Healthcare Services | SHANGHAI, March 26, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced a strategic collaboration with Tencent Health and Tencent Cloud to acc... |
| 24.03.2025 | Fangzhou Inc. Reports Strong Growth in 2024 Annual Results: 11.2% Revenue Growth and 139% Year-on-Year Increase in Adjusted Net Profit Driven by AI-Powered Innovation | HONG KONG, March 24, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced on March 21st, 2025 its financial results for fiscal year 2024, repor... |
| 17.03.2025 | Fangzhou Inc.'s H2H Smart Healthcare Platform Honored as one of Guangdong's Premier High-Tech Innovation Products | GUANGZHOU, China, March 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, today announced that its proprietary "H2H Smart Healthcare Innovati... |
| 24.02.2025 | Fangzhou Inc.: A Rising Star in Internet Healthcare | Fangzhou Inc. is making waves in the world of Internet healthcare. This company, based in China, is not just another player in the field. It’s a leader, a pioneer. With its recent inclusion in the Hang Seng Composite Index, Fangzhou is pois... |
| 24.02.2025 | Fangzhou Inc. Announces Inclusion as a Constituent of the Hang Seng Composite Index | HONG KONG, Feb. 24, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company has been selected and will be included as a con... |
| 18.02.2025 | Fangzhou Inc. integrates DeepSeek open-source AI Model to enhance Internet healthcare | SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced the successful integration and local deployment of the DeepSeek-R1 open... |
| 27.12.2024 | Fangzhou Inc. Honored as an "Outstanding Innovation Firm" by Yangcheng Evening News | GUANGZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored as an "Outstanding Innovation Firm" at the "Pr... |
| 19.12.2024 | Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare | SHANGHAI, Dec. 19, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb ("BMS") China... |
| 17.12.2024 | Fangzhou Inc. Recognized as an "Outstanding Enterprise in Digital Intelligence" by Analysys Star | HANGZHOU, China, Dec. 17, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was recognized as an "Outstanding Enterprise in Digital Intelligence&... |
| 16.12.2024 | Fangzhou Inc. Garners Prestigious "Most Valued Pharmaceutical & Healthcare Enterprise" Award | SHENZHEN, China, Dec. 16, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored with a "Most Valued Pharmaceutical & Healthcare Enter... |
| 03.12.2024 | Fangzhou Inc.: A Rising Star in Internet Healthcare | Fangzhou Inc. is making waves in the world of Internet healthcare. This company, listed on the Hong Kong Stock Exchange, is not just another player in the field. It’s a pioneer, a trailblazer, and now, it’s stepping into the spotlight with ... |
| 03.12.2024 | Fangzhou Inc. Announces Inclusion of Its Shares in Hang Seng Hong Kong-Listed Biotech Index | HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced today that the Company's Ordinary Shares, which trade on The Stock Exch... |
| 02.12.2024 | Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution" | CHENGDU, China, Dec. 2, 2024 /PRNewswire/ -- On November 22, 2024, Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagem... |
| 20.11.2024 | Forging New Paths: Alfasigma Group and Fangzhou Inc. Chart a Course for Internet Healthcare | SHANGHAI, Nov. 20, 2024 /PRNewswire/ -- On November 13th, a high-level delegation from the Alfasigma Group, led by Mr. Andriy Samoylovych, Chief Commercial Officer of Global Growth Markets, and Ms. Zhou Qin, General Manager of Alfasigma Chi... |
| 14.04.2020 | HBM Healthcare Investments and HBM Partners donate protective equipment for emergency hospitals in Switzerland | HBM Healthcare Investments and HBM Partners are making a small but important contribution to the management of the COVID-19 pandemic in Switzerland. Through contacts with the leading Chinese online pharmacy Jianke Pharmaceutical (www.jianke... |
| 05.09.2018 | Chinese online pharmacy Jianke secures $130m in Series B | Guangdong-based online pharmacy and healthcare tech company Jianke 健客(literally “healthy guest”) has secured US$130 million in a Series B round led by GTJA Investment Group with participation from HBM Healthcare Investments and Crescent Poi... |
| 05.09.2018 | China’s online healthcare platform Jianke secures $130m Series B, led by GTJA | Premium
Jianke, the largest online B2C pharmacy platform in China, has closed a $130-million series B financing round led by Shenzhen-based healthcare-dedicated investment firm GTJA Investment Group, according to the company’s announcement ... |
| 04.09.2018 | Jianke Raises US$130M in Series B Financing | Jianke, a Guangzhou, China-based online B2C pharmacy and healthcare services platform, closed a US$130m Series B financing.
The round was led by GTJA Investment Group, with participation from HBM Healthcare Investments and Crescent Point.
T... |
| 04.09.2018 | Term Sheet — Tuesday, September 4 | IPO-BOUND
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
As Bloomberg notes, “Going first would allow Lyft to set expectations for ride-hailing companies, draw attention away fr... |
